Toll-like Receptor 4 is Involved in the Mechanism of Early Alcohol-induced Liver Injury in Mice
Overview
Authors
Affiliations
Chronic alcohol administration increases gut-derived endotoxin in the portal blood, which activates Kupffer cells and causes liver injury. Mice (C3H/HeJ) with mutations in toll-like receptor 4 (TLR4) are hyporesponsive to endotoxin. To test the hypothesis that TLR4 is involved in early alcohol-induced liver injury, the long-term intragastric ethanol feeding protocol developed by Tsukamoto and French for rats was adapted to mice. Animals with nonfunctional TLR4 and wild-type mice (C3H/HeOuJ) were compared. Two-month-old female mice were fed a high-fat liquid diet with either ethanol or isocaloric maltose-dextrin as control continuously for 4 weeks. There was no difference in mean urine alcohol concentrations between the groups. Dietary alcohol significantly increased liver-to-body weight ratios and serum alanine transaminase (ALT) levels in wild-type mice (109 +/- 18 U/L) over high-fat controls (40 +/- 3 U/L), effects that were blunted significantly in mice with a mutation of TLR4 (55 +/- 9 U/L). While no significant pathologic changes were observed in high-fat controls, dietary ethanol caused steatosis, mild inflammation, and focal necrosis in wild-type animals (pathology score = 5.2 +/- 1.2). These pathologic changes were significantly lower in TLR4-deficient mice fed ethanol (score = 2.0 +/- 1.3). Endotoxin levels in the portal vein were increased significantly after 4 weeks in both groups fed ethanol. Moreover, ethanol increased tumor necrosis factor alpha (TNF-alpha) mRNA expression in wild-type, but not in TLR4-deficient, mice. These data are consistent with the hypothesis that Kupffer cell activation by endotoxin via TLR4 is involved in early alcohol-induced liver injury.
BRISC inactivation alleviates alcohol-induced liver injury in mice.
Wang T, Zhang W, Liu X, Liu K, Ren G, Xiang S Sci Rep. 2025; 15(1):5154.
PMID: 39934386 PMC: 11814121. DOI: 10.1038/s41598-025-89796-2.
Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease.
Li W, Gao W, Yan S, Yang L, Zhu Q, Chu H Biomedicines. 2025; 13(1).
PMID: 39857657 PMC: 11761646. DOI: 10.3390/biomedicines13010074.
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD.
Termite F, Archilei S, DAmbrosio F, Petrucci L, Viceconti N, Iaccarino R Antioxidants (Basel). 2025; 14(1).
PMID: 39857390 PMC: 11759774. DOI: 10.3390/antiox14010056.
Feng Y, Chen C, Shao A, Wu L, Hu H, Zhang T Acta Pharm Sin B. 2025; 14(12):5091-5105.
PMID: 39807338 PMC: 11725142. DOI: 10.1016/j.apsb.2024.09.008.
Lv J, Lang G, Wang Q, Zhao W, Shi D, Zhou Z Microb Biotechnol. 2024; 17(10):e70016.
PMID: 39431804 PMC: 11492535. DOI: 10.1111/1751-7915.70016.